Abstract:BACKGROUND Atrial fibrillation (AF) is one of the most common arrhythmia after coronary artery bypass grafting (CABG), which not only increases the suffering of the patients, but also prolongs hospital stay and enhances cost of care, especially for patients older than 70 years. This study was designed to evaluate the efficacy and safety of low-dose amiodarone in the prevention of AF after CABG, especially for the elderly. METHODS Two hundred and ten senile patients undergoing off-pump CABG were included in this prospective, randomized, double-blind and placebo controlled study. Patients were given 10 mg/kg of amiodarone (low-dose amiodarone group, n = 100) or placebo (control group, n = 110) daily for 7 days before surgery and followed by 200 mg of amiodarone or placebo daily for 10 days postoperatively. RESULTS Postoperative AF occurred in 16 patients (16%) receiving amiodarone and in 36 (37.7%) patients receiving placebo (P = 0.006). AF occurred at (58.13 +/- 16.63) hours after CABG in the low-dose amiodarone group and at (45.03 +/- 17.40) hours in the control group (P = 0.018). The maximum ventricular rate during AF was significantly slower in the low-dose amiodarone group ((121.42 +/- 28.91) beats/min) than in the control group ((134.11 +/- 30.57) beats/min, P = 0.036). The duration of AF was (10.92 +/- 9.56) hours for the low-dose amiodarone group compared with (14.81 +/- 10.37) hours for the control group (P = 0.002). The postoperative left ventricular ejection fraction (LVEF) was significantly improved in the low-dose amiodarone group (from (59.9 +/- 10.3)% to (63.4 +/- 11.4)%, P = 0.001), and significantly higher compared with the control group ((58.5 +/- 10.7)%, P = 0.002). Both groups had a similar incidence of complication other than rhythm disturbances (12.0% vs 16.4%, P = 0.368). The low-dose amiodarone group patients had shorter hospital stays ((11.8 +/- 3.2) days vs (13.8 +/- 4.7) days, P = 0.001) and lower cost of care (RMB (79 115 +/- 16 673) Yuan vs RMB (84 997 +/- 21 587) Yuan, P = 0.031) than that of control group patients. The in-hospital mortality was not significantly different between the two groups (1.0% vs 0.9%, P = 0.946). CONCLUSIONS Perioperative low-dose oral amiodarone appeared to be cost-effective in the prevention and delay of new-onset postoperative AF in aged patients. It significantly reduced ventricular rate and duration of AF after CABG, decreased hospital cost and stay, as well as promoted the amelioration of left ventricular systolic function. Furthermore, low-dose amiodarone was safe to use and well tolerated with low toxic and side effects, and did not increase the risk of complications and mortality. It is proved to be a first-line therapy and as routine prophylaxis for AF after CABG, especially for elderly patients complicated with left ventricular dysfunction.

Clinical Efficacy and Safety of Low Dose Amiodoarone in Treatment and Prevention of Elderly Patients with Atrial Fibrillation

Clinical efficacy observation of Amiodarone and Metoprolol on elderly paients with coronary heart disease by cardiac arrhythmias

The effects of amiodarone on QT dispersion in patients with atrial fibrillation

Low-dose amiodarone for the prevention of atrial fibrillation after coronary artery bypass grafting in patients older than 70 years.

The effect of amiodarone on heart rate variability in patients with idiopathic dilated cardiomyopathy

Observation on the Efficacy and Safety of Amiodarone on Patients with Tachyarrhythmia

The Eficacy of Amiodarone for the Cardioversion and the Maintenance of Normal Sinus Rhythm in Patients with Chronic Atrial Fibrillation.

Use of Amiodarone in the Treatment of Atrial Fibrillation:Clinical Observation and Nursing Strategy

An investigation into prevalence of atrial fibrillation in 858 elders

The Effect of Amiodarone on Heart Failure with Ventricular Tachycardia

Clinical Efficacy of Amiodarone in the Treatment of Acute Myocardial Infarction Complicated by Atrial Fibrillation

A Meta-analysis of amiodarone on heart failure and ventricular tachyarrhythmia

Clinical Observation for the Efficacy of Amiodarone in the Treatment of AMI with Life-Treatening Ventriclar Arrhythmia

Meta Analysis of Atrial Fibrillation Treated by Amiodarane or Sotalol

Observing the Effect of Amiodarone Combined with Wenxin Particle on Atrial Fibrillation

Clinical Report of Amiodarone on the Treatment of Ventricular Arrhythmia in 180 Patients with Acute Myocardial Infarction

Electrophysiological and therapeutic effects of amiodarone in patients with preexcited atrial fibrillation

[Effects of Amiodarone Versus Sotalol in Treatment of Atrial Fibrillation: a Random Controlled Clinical Study].

Analysis on efficacy of amiodarone combined with valsartan treating paroxysmal atrial fibrillation

Efficacy, Safety and Outcome of Catheter Ablation for Atrial Fibrillation in Octogenarians

Effect of Amiodarone on Reversion of Atrial Remodeling in Patients with Idiopathic Atrial Fibrillation